20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

John McKearn, Ph.D.

IAC Member

John is a Managing Director at RiverVest Venture Partners. John has almost 30 years’ experience as a successful “drug hunter and developer” in both large and small biopharma, including a decade in small-cap and venture-backed companies. Prior to joining RiverVest, he was president and CEO of Kalypsys, Inc., and has served on the boards of IDM Pharma, Inc. (acquired by Takeda), Epimmune and Keel Pharmaceuticals, Inc. John worked as a scientist with Searle / Pharmacia, from 1987-2003, including head of discovery research from 1997-2003. Through his efforts, John helped establish the groundwork for new studies that led to the commercialization of several major products, including DayPro, Arthrotec, and most notably, Celebrex, one of the leading pharmaceuticals to treat arthritis. Prior to 1987, John was a senior scientist at E.I. DuPont de Nemours and Company; a member of the Basel Institute for Immunology in Basel, Switzerland; and a research associate in the Department of Microbiology and Immunology at Washington University in St. Louis. John completed his PhD in immunology from the University of Chicago and his BS in biology from Northern Illinois University.

Getting Started

Entrepreneurs Investors